CSIMarket Company Name, Ticker, Customers, else..
 
Biolase Inc   (BIOL)
 
Price: $0.0000 $0.00 %
Day's High: 0.00 Week Perf:
Day's Low: $ 0.00 30 Day Perf:
Volume (M): 0 52 Wk High: $ 0.00
Volume (M$): $ 0 52 Wk Avg: $0.00
Open: $0.00 52 Wk Low: $0.00



 Market Capitalization (Millions $) -
 Shares Outstanding (Millions) 36
 Employees 250
 Revenues (TTM) (Millions $) 44
 Net Income (TTM) (Millions $) -33
 Cash Flow (TTM) (Millions $) -4
 Capital Exp. (TTM) (Millions $) 0

Business Description


Biolase Inc is a medical device company that specializes in the development and commercialization of dental lasers. The company was founded in 1987 and is headquartered in Irvine, California. Biolase's flagship product is Waterlase, a dental laser that uses a combination of laser energy and water to perform a range of dental procedures with less pain and faster healing times than traditional methods. In addition to Waterlase, the company also offers other laser-based products for dental and medical applications. Biolase has a global presence and sells its products in over 90 countries worldwide.


   Company Address: 27042 Towne Centre Drive Lake Forest 92610 CA
   Company Phone Number: 361-1200   Stock Exchange / Ticker: BIOL


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
ALGN   -2.91%    
HSIC   -1.26%    
MDT        0.99% 
SYK   -3.99%    
XRAY   -1.91%    
ZBH   -0.84%    
• View Complete Report
   



Stock Offering

BIOLASE Announces $1.4 Million Securities Purchase Agreement, Impacts Shareholders and Reflects a Bullish Future

Published Wed, Dec 6 2023 6:46 PM UTC



LAKE FOREST, Calif., Dec. 6, 2023 - BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, has recently unveiled a major development for the company and its shareholders. This press release reveals that BIOLASE has entered into a securities purchase agreement with a single institutional investor to acquire approximately $1.4 million of its common stocks....



Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) -
Price to Sales (Expected) -
Price to Book -
PEG (TTM) -

Financial Strength Current
Quick Ratio 0.12
Working Capital Ratio 0.66
Leverage Ratio (MRQ) -
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -4.65 $
Revenues (TTM) 1.21 $
Cash Flow (TTM) -
Cash 0.1 $
Book Value -
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 174,880
Net Income per Employee (TTM) -131,812
Receivable Turnover Ratio (TTM) 8.95
Inventory Turnover Ratio (TTM) 2.56
Asset Turnover Ratio (TTM) 1.38

Profitability Ratios Current
Gross Margin (MRQ) 42.21 %
Operating Margin (MRQ) -6.69 %
Net Margin (MRQ) -13.07 %
Net Cash Flow Margin (MRQ) -17.61 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -






Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.